Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Zeneca and University of California to codevelop drugs for immunosuppression

May 8, 1997

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

May 7, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

April 28, 1997

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

April 28, 1997

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

April 28, 1997

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

North American Vaccine's acellular pertussis vaccine approved in Sweden

April 23, 1997

Connaught prepares Bordetella vaccine

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...